6336 Federal Register / Vol. 86, No. 12 / Thursday, January 21, 2021 / Notices 

limited to, sharing identifiable 

information with state and local public 

health departments, and other 

cooperating authorities. CDC and 

cooperating authorities will retain, use, 

delete, or otherwise destroy the 

designated information in accordance 

with federal law and the System of 

Records Notice (SORN) set forth above. 

You may contact the system manager at 

dgmqpolicyoffice@cdc.gov or by mailing 

Policy Office, Division of Global 

Migration and Quarantine, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H16–4, Atlanta, 

GA 30329, if you have questions about 

CDC’s use of your data. 

Authority 

The authority for these orders is 

Sections 361 and 365 of the Public 

Health Service Act (42 U.S.C. 264) and 

42 CFR 71.20 & 71.31(b). 

Dated: January 13, 2021. 

Nina B. Witkofsky, 

Acting Chief of Staff, Centers for Disease 

Control and Prevention. 

[FR Doc. 2021–01067 Filed 1–15–21; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 85 FR 70630–70633, 

dated November 5, 2020) is amended to 

reflect the reorganization of the National 

Center for HIV/AIDS, Viral Hepatitis, 

STD, and TB Prevention, Centers for 

Disease Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the title for the 

National Center for HIV/AIDS, Viral 

Hepatitis, STD, and TB Prevention (CVJ) 

and insert the following title National 

Center for HIV, Viral Hepatitis, STD, 

and TB Prevention (CVJ). 

Revise the mission statement for the 

National Center for HIV, Viral Hepatitis, 

STD, and TB Prevention (CVJ) and 

insert the following: 

National Center for HIV, Viral 

Hepatitis, STD, and TB Prevention 

(CVJ). The National Center for HIV, 

Viral Hepatitis, STD, and TB Prevention 

(NCHHSTP) maximizes public health 

and safety nationally and 

internationally through the elimination, 

prevention, and control of disease, 

disability, and death caused by Human 

Immunodeficiency Virus Infection 

(HIV), non-HIV retroviruses, viral 

hepatitis, other sexually transmitted 

diseases (STDs), and tuberculosis (TB). 

In carrying out its mission, NCHHSTP: 

(1) Builds capacity and enhances public 

health infrastructure for preventing and 

treating HIV, viral hepatitis, STDs, and 

TB; (2) coordinates activities and 

programs across CDC and with other 

Department of Health and Human 

Services Operating Divisions in order to 

maximize the public health impact of 

HIV, viral hepatitis, STDs, and TB 

interventions; (3) conducts surveillance 

and research to determine the 

distribution, determinants, and burden 

of HIV, viral hepatitis, STDs, and TB; (4) 

conducts program evaluation to improve 

programs and activities relating to the 

prevention of HIV, viral hepatitis, STDs, 

and TB, and determine their impact; (5) 

provides reference laboratory and 

clinical diagnostic services for HIV, 

viral hepatitis, STDs, and TB to relevant 

stakeholders; (6) promotes collaboration 

and service integration among HIV, viral 

hepatitis, STDs, and TB programs; (7) 

engages external partners to develop 

and implement effective HIV, viral 

hepatitis, STDs, and TB policies, 

research, and programs; (8) engages 

partners, to promote health equity and 

reduce health disparities among those 

affected by HIV, viral hepatitis, STDs, 

and TB; (9) provides technical 

assistance and training in the diagnosis, 

treatment, and prevention of HIV, viral 

hepatitis, STDs, and TB; (10) conducts 

public health communication activities 

to disseminate research findings and 

increase awareness of HIV, viral 

hepatitis, STDs, and TB; (11) conducts 

operational, behavioral, and biomedical 

research to improve the distribution, 

diagnosis, prevention, and control of 

HIV, viral hepatitis, STDs, and TB; (12) 

provides scientific leadership regarding 

public health ethics and protection of 

human subjects linked to HIV, viral 

hepatitis, STDs, and TB; (13) translates 

research findings into public health 

practice and policy for HIV, viral 

hepatitis, STDs, and TB prevention; (14) 

plans, coordinates, and guides programs 

and activities with external partners, 

federal agencies, and other 

organizations related to HIV, viral 

hepatitis, STDs, and TB prevention, 

care, and treatment; (15) leads and 

participates in the development, 

implementation, and evaluation of 

policies and guidelines related to HIV, 

viral hepatitis, STDs, and TB; (16) 

provides scientific leadership regarding 

screening, treatment, immunization, and 

other prevention interventions relevant 

to HIV, viral hepatitis, STDs, and TB; 

(17) assures all public health decisions 

are based on the highest quality 

scientific data, openly and objectively 

derived; (18) provides leadership to 

assist international partners in 

establishing and maintaining, HIV, viral 

hepatitis, STDs, and TB screening, 

treatment, immunization, and other 

prevention and control programs; (19) 

ensures that programmatic and 

scientific activities are aligned with, and 

in support of, CDC’s overall mission, 

goals, and strategic imperatives; (20) 

allocates and tracks CDC resources and 

contributes to the development of CDC’s 

short-, medium- and long-term strategic 

plans for preventing the spread of HIV, 

viral hepatitis, STDs, and TB; (21) 

collaborates with other federal agencies, 

domestic and international 

governmental and non-governmental 

organizations to advance CDC and 

NCHHSTP health protection goals; and 

(22) coordinates oversight of the 

NCHHSTP Federal Advisory 

Committees. 

Delete in its entirety the titles and 

mission and function statement for the 

Office of the Director (CVJ1) and insert 

the following: 

Office of the Director (CVJ1). (1) 

Provides leadership and guidance on 

the development of goals and objectives, 

policies, program planning and 

development, and program management 

and operations of the activities of 

NCHHSTP and manages, directs, 

coordinates, and evaluates the center’s 

activities; (2) plans and coordinates the 

annual program planning process; (3) 

coordinates with Office of the Director 

(OD), Centers/Institute/Offices (CIOs), 

and divisions in determining and 

interpreting operating policy and in 

ensuring their respective management 

input for specific program activity 

plans; (4) facilitates closer linkages 

between HIV, non-HIV retroviruses, 

STDs, viral hepatitis, and TB, 

surveillance activities and prevention 

programs at all levels, and facilitates 

collaboration, integration, and multidisciplinary approaches to enhance the 

effectiveness of HIV, STD, viral 

hepatitis, and TB prevention programs; 

(5) facilitates collaboration among, and 

integration of, science and prevention 

programs throughout NCHHSTP and 

enhances the coordination and 

integration of HIV, STD, viral hepatitis, 

and TB prevention services for 

individuals and populations at 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 12 / Thursday, January 21, 2021 / Notices 6337 

increased risk for more than one of these 

infections; (6) coordinates the 

integration of CDC funding of state and 

local health departments for HIV, STD, 

viral hepatitis, and TB prevention; (7) 

maximizes center-wide collaboration to 

promote and support Program 

Collaboration and Service Integration 

(PCSI) in state and local HIV, viral 

hepatitis, STD and TB programs to 

increase efficiencies and provide 

comprehensive evidence based 

prevention services to impacted 

populations; (8) develops partnership 

objectives and strategies for advancing 

center priorities (e.g., on cross-cutting 

functions PCSI, reducing health 

disparities, etc.) and leverages OD 

resources to address these objectives 

and strategies; (9) coordinates and tracks 

health equity science and program 

activities within the center; (10) 

coordinates and tracks science and 

program activities that concern or 

address social determinants of health 

within NCHHSTP and other programs; 

(11) collaborates with the CDC OD and 

other CDC components on health equity 

activities, and works with the CDC OD 

to monitor progress in meeting 

Executive Orders related to improving 

minority health; (12) develops 

partnerships with other federal agencies 

and nongovernmental organizations 

working on similarly-affected 

populations; (13) supports research, 

surveillance, education, training, and 

program development to achieve health 

equity and reduce health disparities; 

(14) sponsors workgroups, meetings, 

and conferences related to health equity; 

(15) promotes a diverse public health 

workforce through internships, 

fellowships, training programs, and 

other activities; (16) ensures process 

consistency for laboratory related 

functions within NCHHSTP and across 

the CIOs; (17) facilitates cross-center 

decision-making regarding laboratory 

activities; (18) monitors the performance 

of funded extramural research projects 

in the areas of HIV, viral hepatitis, STD 

and TB; (19) collaborates with other 

federal agencies to advance prevention 

through healthcare; (20) coordinates and 

supports cross-cutting strategic 

initiatives in support of NCHHSTP 

divisions and partners; and (21) works 

across the agency to advance prevention 

priorities. 

Delete item (3) of the functional 

statement for the Office of the Associate 

Director for Science (CVJ12), and insert 

the following: (3) Facilitates 

communication regarding scientific and 

programmatic services across the 

Deputy Director of Infectious Diseases 

(DDID). 

Delete in its entirety the titles and 

mission and function statements for the 

Division of HIV/AIDS Prevention— 

Intervention and Support (CVJB). 

Delete in its entirety the titles and 

mission and function statements for the 

Division of HIV/AIDS Prevention— 

Surveillance and Epidemiology (CVJC) 

and insert the following: 

Division of HIV Prevention (CVJC). (1) 

Conducts national HIV surveillance, 

oversees the implementation of HIV 

prevention and control programs, 

conducts HIV research, and evaluates 

the impact of division’s program and 

research activities in collaboration with 

other CDC CIOs; (2) provides 

consultation, financial, and technical 

services to assist others in the planning, 

development, implementation, 

evaluation and overall improvement of 

HIV prevention programs; (3) conducts 

research into factors affecting the 

prevention of HIV; (4) provides strategic 

vision, planning, and coordination for 

implementation of policies and 

programmatic activities that address the 

Ending the HIV Epidemic initiative in 

collaboration with the center, CDC OD, 

and other CIO; (5) provides strategic 

direction of program-led science by 

overseeing the refinement of the 

Division of HIV Prevention’s (DHP) 

scientific research agenda and 

coordination of DHP priorities; (6) 

counsels leadership in building and 

aligning strategic partnerships at the 

executive-level and communicates 

internally and externally about 

partnership priorities; (7) works closely 

with CDC stakeholders on HIV 

surveillance and epidemiologic 

investigations that require laboratory 

collaboration, and on activities related 

to the investigation and prevention of 

HIV-related opportunistic infections; (8) 

promotes linkages between health 

departments’ HIV programs, and other 

governmental and nongovernmental 

partners who are vital to HIV prevention 

efforts; (9) develops preventive health 

services models, recommendations, and 

guidelines on the prevention of HIV and 

associated illnesses; (10) monitors 

surveillance of risk behaviors associated 

with HIV transmission, infectious 

diseases, and other complications of 

HIV; (11) develops methods and 

guidance, and provides technical 

assistance to support health 

departments to build capacity for cluster 

and outbreak response; (12) determines 

risk factors and transmission patterns of 

HIV by conducting HIV surveillance, 

epidemiologic investigations, and 

research studies; (13) works closely with 

other governmental and 

nongovernmental agencies, and the 

health care community to enhance and 

evaluate HIV prevention services in 

public and private health care delivery 

systems; (14) implements national HIV 

prevention public information programs 

and assists in developing strategic 

communications activities and services 

at the national level to inform and 

educate the American public about HIV, 

especially clinical providers, persons 

with HIV and groups at high risk for 

acquiring HIV; (15) manages, develops 

and directs the implementation of the 

division data policy, management, and 

governance, provides IT coordination 

and support for enterprise level shared 

services, and coordinates with other 

parts of CDC to ensure adherence to 

CDC’s IT governance and data 

modernization policies; (16) provides 

information on HIV to CDC partners, 

scientific communities, and the general 

public through publications and 

presentations; and (17) collaborates with 

UNAIDS, the World Health 

Organization and other partners on HIV 

surveillance and epidemiology. 

Office of the Director (CVJC1). (1) 

Plans, directs, and evaluates activities of 

the division; (2) serves as the division’s 

liaison to the center policy office, the 

CDC OD, HHS, GAO and OIG, CDC 

Washington and the Office of 

Appropriations to address inquiries, 

develop the President’s budget, review 

legislation, and support outreach to 

educate policy makers; (3) manages 

strategic planning and coordinates 

related reporting; (4) identifies, analyzes 

and addresses policy barriers and leads 

legal assessment efforts; (5) provides 

strategic direction, goals, and priorities 

to build and evaluate the effectiveness 

of division partnerships, in coordination 

with DHP branches and offices, 

including expanding public private 

partnerships, community-level 

partnerships, and engaging special 

populations; (6) monitors internal and 

external environmental shifts to identify 

and analyze potential and real 

reputational risk issues and develops 

responses to anticipated issues to lessen 

their impact; (7) provides critical vision 

and communication counsel to DHP 

leadership, aligns messaging across the 

division, and develops, coordinates, and 

finalizes strategic communication plans, 

messaging, partner communications, 

social media, and other communication 

materials; (8) advances DHP 

programmatic priorities through 

proactive stakeholder communication 

and liaises with the Center News Media 

team; (9) develops goals and objectives 

and provides guidance in national HIV 

prevention policy formulation and 

program planning and development; 

(10) leads the development and 


jbell on DSKJLSW7X2PROD with NOTICES
6338 Federal Register / Vol. 86, No. 12 / Thursday, January 21, 2021 / Notices 

provides oversight of the research 

agenda and ensures the scientific 

integrity of research, surveillance, 

evaluation, and other scientific aspects 

of HIV prevention, and coordinates 

these activities with other center 

divisions, CIOs, federal agencies and 

other prevention partners as needed; 

(11) oversees and coordinates 

prevention and control program 

implementation and coordinates 

activities with other center divisions, 

CIOs, federal agencies, and other 

prevention partners; (12) provides 

oversight for the integrity and quality of 

division science, including review of 

protocols and other scientific products 

and projects, scientific clearance, and 

compliance with all federal rules and 

regulations regarding research and nonresearch projects, and conducts 

scientific training; (13) coordinates 

international HIV activities of the 

division and ensures inter-divisional 

coordination within the center and CDC, 

as appropriate; (14) in the international 

setting, evaluates biomedical, structural, 

or combination interventions to prevent 

HIV infection and reduce HIV morbidity 

and mortality; (15) in the international 

setting, conducts and facilitates 

diagnostic evaluations and 

epidemiologic investigations to increase 

the diagnosis and prevention of HIV 

infection; (16) provides support and 

guidance for program management and 

operations, including the coordination 

and development of CDC and divisionwide training and educational programs, 

workforce development and succession 

planning; (17) provides management, 

oversight, and services support for 

intramural and extramural program 

management; (18) provides health 

equity strategic vision for the division, 

offices, and branches and collaborates 

with branches to monitor progress 

toward achieving national agency, 

center and division health equity goals; 

(19) leads the development and 

provides oversight of the health equity 

research and programmatic agenda for 

the division, and serves as liaison to key 

stakeholder groups related to health 

inequities and HIV issues; (20) oversees 

and coordinates the development, 

maintenance, and reporting of national 

indicators for the prevention of HIV by 

working with HHS, other federal 

agencies, and partners; (21) provides 

support and reviews logic models and 

performance measures for Notice of 

Funding Opportunity Announcements 

for the division; (22) conducts data 

driven reviews for program planning 

and performance assessment; (23) 

oversees, develops, and directs the 

division’s data policy framework, data 

management framework, and data 

governance implementation; (24) 

coordinates with other parts of CDC to 

ensure adherence to CDC’s IT 

governance and data modernization 

policies; (25) manages the acquisition, 

receipt, quality assessment, and 

provisioning of non-CDC data resources; 

and (26) provides division-level IT/ 

Informatics coordination and support 

for enterprise-level shared services. 

HIV Research Branch (CVJCB). (1) 

Designs and conducts clinical, 

epidemiologic, implementation, health 

services, and behavioral research 

studies and trials to increase HIV 

diagnosis, prevention, and treatment, 

and to optimize health outcomes of 

people with HIV; (2) conducts 

implementation research to understand 

and evaluate strategies to increase 

uptake, delivery and sustainability of 

HIV prevention interventions; (3) 

designs and conducts research to 

understand determinants of disparities, 

including social determinants of health, 

and to promote health equity in HIV 

prevention and treatment; (4) conducts 

studies to evaluate, improve, and 

standardize laboratory technologies 

used for diagnosis and monitoring of 

HIV infection and for supporting 

adherence to biomedical HIV prevention 

and treatment interventions; (5) 

conducts demonstration projects of 

novel prevention strategies delivered by 

health departments, community-based 

organizations (CBO), healthcare 

organizations, and other providers; (6) 

contributes to the field of HIV 

prevention by producing and 

disseminating scientific evidence and 

by providing expert consultation to 

stakeholders; (7) collaborates with key 

stakeholders in identifying research 

priorities and in designing and 

conducting research; (8) supports 

partners in investigating unusual HIV 

transmission and cluster and outbreak 

investigations; and (9) participates in 

the development of guidelines, based on 

scientific investigations and clinical 

trials, for HIV prevention and for 

prevention of adverse outcomes of HIV 

infection. 

Behavioral and Clinical Surveillance 

Branch (CVJCC). (1) Conducts 

surveillance of behaviors related to 

acquisition or transmission of HIV 

infection in high risk populations to 

evaluate the impact of the national or 

jurisdiction’s overall prevention 

portfolio to direct prevention resource 

allocation; (2) develops, uses, and 

disseminates methods to monitor 

behaviors associated with HIV 

transmission or acquisition; (3) 

conducts clinical surveillance through 

in-depth interviews of persons with 

diagnosed HIV to assess access to 

medical care and prevention services, 

adherence to therapy, and behavioral 

risk associated with HIV transmission; 

(4) conducts clinical surveillance 

through in-depth chart reviews of 

persons with diagnosed HIV in selected 

sites to monitor morbidity and mortality 

and to assess access to and quality of 

care; (5) develops, uses, and 

disseminates methods to monitor 

clinical care and health outcomes for 

people with diagnosed HIV; (6) 

conducts behavioral or clinical 

surveillance in special populations of 

epidemiologic importance; (7) 

maintains, analyzes, and disseminates 

information from national surveys of 

behaviors associated with HIV testing, 

prevention, acquisition, or transmission; 

(8) collaborates with internal and 

external partners to ensure high quality 

behavioral and clinical monitoring 

systems, including screening for, and 

monitoring of comorbidities in key 

populations; (9) oversees and manages 

intramural and extramural funding, 

ensures regulatory compliance, provides 

technical assistance, and monitors 

program implementation related to 

behavioral and clinical surveillance; 

(10) provides support for outbreak 

response; and (11) provides subject 

matter expertise and support related to 

high risk populations and to medical 

care for people with HIV. 

Quantitative Sciences Branch 

(CVJCD). (1) Designs, develops, and 

implements statistical, data science, 

economic, cost, and resource allocation 

strategies, models, and methodologies; 

(2) collaborates with scientists, program 

experts, and senior public health 

officials throughout the division to 

apply quantitative science models and 

methodologies to HIV surveillance and 

prevention studies and prevention 

program activities; (3) develops and 

implements mathematical models to 

project the effects of prevention and 

care interventions on future HIV 

incidence, prevalence, transmission 

rates, and costs associated with HIV to 

determine the most efficient allocation 

of HIV prevention resources; (4) 

develops and reviews the statistical 

content of study designs and protocols, 

analysis plans, and scientific and 

communication products; and (5) 

applies novel analytic algorithms and 

visualization approaches to extract 

actionable HIV-prevention-related 

information from suitable nontraditional data types and sources. 

HIV Surveillance (CVJCE). (1) 

Conducts population based, national 

HIV surveillance to monitor and 

characterize HIV trends, transmission 

risk, clinical outcomes, and 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 12 / Thursday, January 21, 2021 / Notices 6339 

antiretroviral resistance to guide public 

health action at the federal, state, and 

local levels; (2) develops and 

implements HIV surveillance technical 

guidance, methods, protocols, and 

program standards for analysis and data 

system applications for the collection, 

evaluation, analysis, security and 

confidentiality, and dissemination of 

HIV surveillance data; (3) maintains, 

analyzes, integrates and disseminates 

information from the national HIV 

surveillance and related systems; (4) 

promotes uses of surveillance data to 

inform HIV prevention and care efforts, 

resource allocation, public health policy 

development and evaluation; (5) 

conducts projects for populations of 

epidemiologic importance and 

advancement of surveillance methods; 

(6) evaluates HIV surveillance systems, 

develops and implements improved 

surveillance methodologies, and 

conducts data driven technical 

assistance; (7) oversees and manages 

extramural funding for surveillance 

activities and provides programmatic, 

budgetary, and technical assistance to 

state and local health departments and 

other external partners to ensure highquality state, local and national HIV 

surveillance data; (8) collaborates with 

internal and external partners and 

supports cluster and outbreak detection 

and investigation; and (9) collaborates 

with internal and external stakeholders 

to enhance surveillance quality, data 

use, and provide expert consultation. 

Laboratory Branch (CVJCG). (1) 

Conducts studies of HIV and other 

human and zoonotic retroviruses, 

including the diseases they cause and 

their modes of transmission, through 

virus detection, isolation, and 

characterization by virologic, molecular, 

and cellular biologic methods; (2) 

collaborates with DHP and other 

investigators to conduct HIV 

epidemiologic and surveillance studies 

as they pertain to testing, prevention, 

and intervention strategies; (3) conducts 

and supports field and clinical studies 

for HIV prevention; (4) develops 

collaborations with other CDC and nonCDC scientists to promote scientific 

progress and accomplishments; (5) 

collaborates with industry to promote 

commercialization of useful technology, 

methodologies, or reagents of public 

health importance; (6) serves as a 

reference laboratory for state and local 

health departments; (7) conducts studies 

related to the development, evaluation, 

improvement, and standardization of 

laboratory technologies used for the 

diagnosis, surveillance, and monitoring 

of HIV infection both independently 

and in collaboration with the 

biotechnology industry; (8) performs 

HIV testing in support of the diagnostic, 

surveillance, and epidemiologic 

requirements of CDC-based and CDCaffiliated studies of HIV; (9) provides 

diagnostic services to other federal 

agencies, academic centers, CDCaffiliated studies with other countries, 

and community organizations, as 

appropriate; (10) develops and evaluates 

novel biomedical prevention and 

treatment modalities in preclinical 

animal models; (11) evaluates and 

develops HIV testing technologies; (12) 

researches, develops, and evaluates 

bioinformatics tools to better 

understand HIV spread to inform 

prevention efforts; (13) provides 

antiretroviral drug testing in support of 

clinical, preclinical, and surveillance 

activities; and (14) collaborates with 

internal and external partners and 

supports cluster and outbreak detection 

and investigation. 

HIV Prevention Capacity and 

Development Branch (CVJCH). (1) 

Assesses HIV prevention and treatment 

training and technical assistance needs 

of DHP program funding recipients, 

clinicians, and other HIV prevention 

service providers and develops and 

delivers strategies and products to 

address identified needs; (2) develops, 

maintains, and manages systems to 

ensure that health department and CBO 

staff receive appropriate and timely 

training and technical assistance; (3) 

provides subject matter expertise on 

HIV prevention and treatment to ensure 

that training and technical assistance 

products developed by capacity 

building providers are aligned with 

HHS and CDC strategic goals and 

objectives, center and DHP priorities, 

and support the training and technical 

assistance needs of DHP program 

funding recipients, clinicians, and other 

HIV prevention service providers; (4) 

collaborates with DHP staff and capacity 

building providers to synthesize 

research findings and disseminate 

technical assistance and training 

products relevant to the needs of HIV 

prevention programs and clinicians; and 

(5) manages national conference 

contract and support services. 

Prevention Communications Branch 

(CVJCI). (1) Develops, disseminates, and 

evaluates evidence-based HIV messages, 

communication campaigns, programs, 

and partnership efforts through multiple 

channels to stakeholders, health care 

providers, persons at risk for and living 

with HIV, and the general public; (2) 

maintains division communication 

infrastructure, including social media, 

Web, and SharePoint channels, the 

curation of CDC’s HIV print inventory, 

and oversight of the HIV subject matter 

expertise of CDC–INFO; and (3) 

collaborates and consults with CDC 

staff, HHS, state and local health 

departments, and other groups and 

organizations involved in HIV 

prevention communication activities to 

devise and facilitate technical assistance 

systems and activities related to the 

application of social marketing and 

communication science to prevention 

programs and policies. 

Program Development and 

Implementation Branch (CVJCJ). (1) In 

collaboration with state and local public 

health and non-governmental national, 

regional, and local partners, CIOs, and 

other federal agencies, develops and 

implements programs, policies, and 

activities that enable and mobilize 

affiliates and communities to become 

involved with, and support, strategic 

community planning that improves HIV 

prevention programs and activities; (2) 

plans, develops, implements, and 

manages strategies and resources that 

build a comprehensive public healthprivate sector partnership to prevent 

HIV and its complications; (3) provides 

technical consultation and assistance to 

local, state, and territorial health 

departments, integrated HIV prevention 

and care planning groups, nongovernmental, other prevention 

partners, and tribal governments and 

organizations in operational aspects of 

HIV prevention; (4) monitors 

implementation and maintenance of 

HIV prevention programs through the 

application of program science to ensure 

operational objectives are being met; (5) 

establishes guidance and policies for 

implementation and continuation of 

local, state, and territorial HIV 

prevention programs; (6) provides 

technical review of grant applications 

and prevention work plans; (7) 

coordinates program development and 

implementation with local, state, and 

territorial integrated HIV prevention and 

care planning groups; (8) facilitates 

linkages with HIV and other infectious 

diseases prevention programs at all 

levels to maximize coordination of harm 

reduction and intervention strategies 

tailored for populations with complex 

psychosocial prevention needs; (9) 

works with national partners to foster 

HIV prevention capabilities and 

activities in affected communities; (10) 

monitors the progress of funded 

recipients implementing HIV prevention 

programs and activities; (11) promotes 

and facilitates the application of social 

marketing principles to HIV prevention 

at the state and local levels; (12) plans, 

implements, and manages DHP’s 

programmatic notice of funding 

opportunities (NOFOs) for health 


jbell on DSKJLSW7X2PROD with NOTICES
6340 Federal Register / Vol. 86, No. 12 / Thursday, January 21, 2021 / Notices 

departments, community-based 

organizations, and national partners and 

providers; (13) provides monitoring and 

oversight to programmatic NOFO 

activities throughout the funded 

lifecycle; (14) supports the federal 

Ending the HIV Epidemic workforce 

that provides technical consultation and 

direct assistance to state, local health 

departments implementing HIV 

prevention programs; and (15) assesses 

training, capacity building and technical 

assistance needs and develops strategies 

to address the training of recipient 

organizations and other external 

partners involved in HIV prevention 

programs and activities. 

Translation and Evaluation Branch 

(CVJCK). (1) Collaborates with DHP, 

CDC, HIV prevention program 

recipients, and national partners to 

systematically collect, process, and use 

HIV prevention program data and 

research findings for program planning, 

monitoring, evaluation, and 

improvement; (2) identifies and 

prioritizes program needs and research 

gaps, synthesizes research and program 

findings, selects and translates HIV 

prevention research findings, and 

collaborates within DHP to support 

development and dissemination of 

guidelines, research syntheses and 

effective strategies for HIV prevention 

programs; (3) creates, maintains and 

regularly updates a public-facing 

platform to disseminate evidence-based 

prevention strategies and research 

syntheses aligned with DHP and 

national prevention priorities to internal 

and external stakeholders; (4) creates 

and manages a continuously updated 

multi-level coded cumulative database 

of the HIV prevention research literature 

in support of systematic reviews and 

guideline development as well as 

internal and public inquiries; (5) seeks 

to advance the methodology of HIV 

prevention evaluation through CDC 

evaluation activities and with the field 

of program evaluation more broadly; (6) 

seeks to improve data quality and 

support through providing assistance to 

recipients to help design and implement 

data collection, design local evaluations, 

and dissemination packages; (7) collects 

information to verify that what is 

developed, translated and disseminated 

is feasible, programmatically effective, 

and plays a role in improving health 

outcomes; (8) plans, develops, 

implements, and manages research 

dissemination strategies and resources 

that build a research to practice 

infrastructure to prevent HIV and its 

complications; (9) monitors 

implementation and establishes 

protocols for implementation of 

behavioral, biomedical, structural 

evidence-based and evidence-informed 

approaches by HIV prevention programs 

to determine if said approaches may be 

successfully implemented under real 

world conditions; (10) collaborates and 

consults with CDC staff, other Public 

Health Service agencies, state and local 

health departments, CBOs, and other 

groups and organizations involved in 

HIV prevention activities to support 

technical assistance systems and other 

activities related to the application of 

evidence-informed and evidence-based 

prevention programs and policies; (11) 

provides scientific expertise, quality 

assurance and clearance for products 

and processes related to systematic 

review, research synthesis, and 

guidelines methodologies; and (12) 

collaborates within DHP to provide 

technical consultation and assesses and 

determines the training, capacity 

building, and technical assistance needs 

for organizations implementing 

behavioral, biomedical, and structural 

evidence-based and evidence- informed 

approaches to meet the unique HIV 

prevention needs of local jurisdictions 

based upon risk factors and 

demographics. 

Detection and Response Branch 

(CVJCL). (1) Develops and disseminates 

analytic methods for detecting and 

prioritizing clusters and outbreaks and 

understanding transmission patterns, 

molecular epidemiology, and drug 

resistance; (2) analyzes data to identify 

and monitor priority clusters and 

support public health action; (3) 

provides technical assistance and other 

support for health departments on 

detecting clusters and outbreaks; (4) 

develops, evaluates, and disseminates 

methods for responding to clusters and 

outbreaks; (5) develops guidance and 

provides technical assistance to support 

health departments to build capacity for 

cluster response and response planning, 

including community engagement; (6) 

leads cross-division collaboration and 

communication about cluster and 

outbreak detection and response and 

builds DHP capacity to support 

response, including training and 

rostering staff; (7) provides technical 

assistance and other support for health 

departments on responding to clusters 

and outbreaks and disseminates 

findings of these responses; (8) analyzes 

information from cluster detection and 

response to inform efforts to prevent 

clusters and outbreaks; (9) provides 

scientific and programmatic oversight 

and guidance for DHP informatics 

systems for cluster detection and 

response and collaborates with other 

DHP branches and offices on these 

systems; and (10) collaborates with 

other branches and offices in DHP, 

divisions in the center, and CIOs to 

harmonize scientific agendas and 

programmatic priorities and addresses 

community engagement and policy 

issues related to cluster detection and 

response. 

Delete item (2) of the functional 

statement for the Division of Adolescent 

and School Health (CVJJ), and insert the 

following: (2) Identifies and monitors 

priority sexual health risks and related 

health behaviors among youth that 

result in the transmission of HIV, other 

sexually transmitted infections and 

unintended pregnancy. 

Delete item (2) of the functional 

statement for the Program Development 

and Services Branch (CVJJB), and insert 

the following: (2) Uses the results of 

surveillance and evaluation research 

and research syntheses to improve the 

impact of school- and community-based 

interventions designed to reduce 

priority health risks among youth and to 

promote changes in behaviors related to 

HIV, other sexually transmitted 

diseases, and unintended pregnancy. 

Sherri Berger, 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2021–01213 Filed 1–19–21; 8:45 am] 

BILLING CODE 4160–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Proposed Information Collection 

Activity; Monitoring and Compliance 

for Office of Refugee Resettlement 

Care Provider Facilities (New 

Collection) 

AGENCY: Office of Refugee Resettlement, 

Administration for Children and 

Families, Department of Health and 

Human Services. 

ACTION: Request for public comment. 

SUMMARY: The Office of Refugee 

Resettlement (ORR), Administration for 

Children and Families (ACF), U.S. 

Department of Health and Human 

Services (HHS), is inviting public 

comments on the proposed collection. 

The request consists of several forms 

that allow the Unaccompanied Alien 

Children (UAC) Program to monitor its 

care provider facilities for compliance 

with federal and state laws and 

regulations, licensing and accreditation 

standards, ORR policies and procedures, 

and child welfare standards. 


jbell on DSKJLSW7X2PROD with NOTICES